Hairy Cell Leukemia

Justin M. Watts*, Martin S. Tallman

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter


This chapter presents two case studies and series of question and answers on hairy cell leukemia (HCL). It commences with a discourse on how minimal residual disease (MRD) defined, and also MRD on portend relapse in HCL, and ends with the question on best front-line therapy in a symptomatic pregnant patient with HCL. The chapter also discusses on whether a patient relapses after a single cycle of cladribine and best therapeutic approach, and best treatment for patients with multiply relapsed HCL and a role for hematopoietic cell transplantation (HCT).

Original languageEnglish (US)
Title of host publicationCancer Consult
Subtitle of host publicationExpertise for Clinical Practice
Number of pages6
ISBN (Electronic)9781118589199
ISBN (Print)9781118589212
StatePublished - Jun 20 2014


  • Hairy cell leukemia (HCL)
  • Minimal residual disease (MRD)

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Hairy Cell Leukemia'. Together they form a unique fingerprint.

Cite this